Why Many Doctors Don’t Believe Chronic Lyme Disease

“My doctor told me it’s all in my head.”

If you have been told your persistent symptoms are imaginary, exaggerated, or unrelated to Lyme disease—you are not alone.

The dismissal many patients experience is real.

Not all physicians dismiss persistent Lyme symptoms. Many are working within training systems, institutional guidelines, insurance pressures, and scientific frameworks that do not fully reflect the complexity of chronic tick-borne illness.

This page is not about blame—it is about understanding why this gap exists so patients can navigate care more effectively.

Many individuals are told Lyme disease does not last that long, that further treatment is unnecessary, or that they should simply accept a diagnosis of post-treatment Lyme disease syndrome (PTLDS) and move on.

This often leads to confusion, frustration, and medical abandonment.

Understanding why many doctors don’t believe chronic Lyme disease requires examining medical education, institutional guidelines, scientific controversy, economic pressures, and deeply embedded assumptions about what Lyme disease “should” look like.

Medical Training Shapes What Doctors Believe Is Possible

Physicians are commonly taught that Lyme disease is easy to diagnose, straightforward to treat, and fully resolved after several weeks of antibiotics.

This framework is reinforced through medical schools, board examinations, textbooks, and continuing medical education.

The problem is that clinical reality is often more complicated.

Many patients never develop a bull’s-eye rash. Many are not diagnosed early. And some continue experiencing symptoms long after standard treatment.

When a physician trained in the textbook model encounters a patient who does not fit that pattern, the instinct is often to question the diagnosis—not the model itself.

I was trained within this same framework. Early in my career, I believed what I had been taught. Only after seeing patient after patient who did not fit the expected recovery pattern did I begin questioning whether the model itself was incomplete.

Institutional Guidelines Create Professional Risk

Medical guidelines are intended to standardize care and improve quality. But in Lyme disease, guidelines can also create professional constraints.

Organizations such as the Infectious Diseases Society of America (IDSA) state that Lyme disease is rarely chronic and that prolonged antibiotic treatment is generally unsupported by evidence.

Physicians who deviate from these recommendations may face:

• Medical board scrutiny
• Insurance denials
• Professional criticism
• Legal or malpractice concerns

This creates a chilling effect. Even physicians who privately recognize limitations in current guidelines may feel unable to act on those concerns.

Not all physicians have the freedom to practice outside institutional expectations.

Economic and System Pressures

Modern medical systems reward efficiency.

Short visits, insurance restrictions, and documentation demands limit the time available for complex chronic illness.

Lyme disease often presents as a multisystem illness involving fatigue, pain, cognition, sleep, and autonomic dysfunction.

These patients require time and individualized evaluation.

When the medical system does not support complexity, dismissal can become the default response.

The PTLDS vs. Chronic Lyme Debate

Terminology shapes treatment decisions.

PTLDS assumes infection has been eradicated and persistent symptoms are unrelated to active infection.

Chronic Lyme disease allows for the possibility of persistent infection, immune dysregulation, biofilm persistence, or untreated co-infections.

The terminology used often determines whether symptoms are investigated—or dismissed.

Labels should not be used to shut down clinical inquiry.

Scientific Uncertainty Is Often Presented as Certainty

There is ongoing debate about:

• Persistent infection
• Biofilm survival mechanisms
• Immune dysregulation
• The role of co-infections

These are legitimate scientific questions. Research continues evolving.

Yet many patients are told the science is settled and that chronic Lyme disease cannot exist.

Scientific uncertainty does not justify certainty in dismissal.

When I evaluate a patient whose illness began after tick exposure, whose symptoms match patterns I have seen repeatedly, and whose recovery stalled after standard treatment, I do not dismiss their experience simply because the research remains incomplete.

The Result: Medical Abandonment

Patients frequently describe:

• Loss of trust in the medical system
• Psychological harm from dismissal
• Delayed diagnosis
• Financial burden seeking care elsewhere
• Isolation and frustration

This is what I call medical abandonment—the failure to provide ongoing care when illness does not fit an accepted framework.

I have spent much of the past year developing an ethics-based framework around this issue.

Patients deserve physicians who listen without prejudgment, acknowledge uncertainty honestly, and continue investigating persistent symptoms even when answers remain incomplete.

What Patients Can Do

Understanding why dismissal happens does not make it acceptable—but it may help patients navigate the system more effectively.

Patients experiencing dismissal should:

• Seek Lyme-literate physicians
• Document symptoms carefully
• Request further evaluation when appropriate
• Avoid internalizing dismissal

If a physician tells you your symptoms are impossible, that often reflects limitations in the framework—not the validity of your illness.

What Medicine Owes Patients

Medicine has a responsibility to:

• Acknowledge uncertainty honestly
• Investigate persistent symptoms
• Provide continuity of care
• Respect patient autonomy
• Revise guidelines as evidence evolves

Progress is occurring slowly as research into persistent infection, neuroinflammation, immune dysfunction, and co-infections expands.

But many patients continue suffering while waiting for the system to catch up.

There is hope. Better recognition of persistent Lyme disease patterns, improved research models, and growing awareness of medical abandonment are slowly reshaping the conversation.

Clinical Takeaway

Chronic Lyme disease is often dismissed not because patients are wrong, but because the medical system struggles to address complex chronic illness that falls outside established frameworks.

Medical training, institutional guidelines, scientific controversy, and economic pressures all contribute to a culture where dismissal becomes normalized.

You are not imagining your symptoms. You deserve investigation, respect, and ongoing care.

If you are still searching for answers, do not give up. Recovery is possible.

Frequently Asked Questions

Why do doctors dismiss chronic Lyme disease?

Because of medical training, institutional guidelines, insurance pressures, professional risk, and scientific uncertainty that is often presented as settled fact.

What is the difference between PTLDS and chronic Lyme disease?

PTLDS assumes infection has been eradicated, while chronic Lyme disease allows for ongoing infection, immune dysfunction, or untreated co-infections.

Can patients be dismissed even with positive Lyme tests?

Yes. Some physicians follow strict treatment frameworks regardless of persistent symptoms or prior positive testing.

What should patients do if they are dismissed?

Seek a Lyme-literate physician, document symptoms carefully, and continue advocating for appropriate evaluation.

Is medical abandonment recognized as an ethical issue?

Increasingly yes. Many experts now recognize that patients with persistent complex illness are often left without adequate care or investigation.

---

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention